Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2004
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomasJohn L Marshall, James L Gulley, Philip M Arlen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2016
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell TransplantationGabriel N Mannis, Thomas G Martin, Lloyd E Damon, et al.Cancer Chemotherapy and Pharmacology|September 28, 2012
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapyMichael J Pishvaian, Rebecca Slack, Eunice Y Koh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical OpinionDebyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.Journal of Surgical Oncology|May 7, 2024
Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross-sectional imagingJoshua M K Davis, Muhammad Khalid Khan Niazi, Ansley B Ricker, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and miceJean Y Tang, Michelle Aszterbaum, Mohammad Athar, et al.JCI Insight|July 21, 2017
Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapyKimberly Loo, Katy K Tsai, Kelly Mahuron, et al.Cancer|August 18, 2016
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodiesAlain P Algazi, Katy K Tsai, Alexander N Shoushtari, et al.Blood Advances|July 11, 2018
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphomaJames L Rubenstein, Huimin Geng, Eleanor J Fraser, et al.Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.Pageof 9